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Q Fever Cholecystitis in an Unvaccinated Butcher
Diagnosed by Gallbladder Polymerase Chain Reaction
Mel Figtree,1 Spiros Miyakis,1 John Stenos,2 Stephen Graves,2 Susan Botham,3
Mark Ferson,3 and Steven Krilis1
Abstract
Acalculous cholecystitis has been described in association with Q fever. We describe the first known case of Q
fever cholecystitis diagnosed by polymerase chain reaction on gallbladder tissue. The presence of Coxiella burnetii
genome in the diseased gallbladder tissue argues for direct involvement of the organism in the pathogenesis of Q
fever cholecystitis.
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This is the first known report of Q fever cholecystitisdiagnosed by polymerase chain reaction (PCR) on the
surgically removed gall bladder. A 38-year-old man was ad-
mitted to a Sydney teaching hospital with a 6-day history of
fever, lethargy, myalgia, headache, and vomiting. He had
worked for 6 months as a meat packer at a wholesale butcher.
Workplace investigation revealed that his job entailed cutting
frozen carcasses of cattle, sheep, and pigs with a high-speed
saw, a process that generates spray, despite which no personal
precautions against aerosol exposure were utilized. There was
no history of Q fever vaccination. On examination the patient
was febrile to 39.98C, and had severe headache with mild
photophobia and nonspecific abdominal tenderness.
Transaminases were raised with alanine aminotransferase
148 U=L (<45 U=L) and aspartate aminotransferase 150 U=L
(<45 U=L). Alkaline phosphatase, gammaglutamyl transfer-
ase, and bilirubin were normal. C reactive protein was raised
at 76 mg=L (<3 mg=L), and leucocyte count was 6.23109=L
(3.50–11.00109=L) with a lymphopenia of 0.8109=L (1.5–
4.0109=L). Cultures from blood, urine, and cerebrospinal
fluid (CSF) were sterile. A presumptive diagnosis of Q fever
was made on day 3, and the patient was commenced on
doxycycline.
The patient’s condition initially improved. However, on
day 6 he developed severe right upper quadrant abdominal
pain and fever to 38.58C. Transaminases increased (alanine
aminotransferase 325 U=L and aspartate aminotransferase
349 U=L), with evidence of cholestasis: bilirubin 61 mmol=L (0–
25mmol=L), alkaline phosphatase 287 U=L (38–126 U=L), and
gammaglutamyl transferase 222 U=L (0–50 U=L). Abdominal
ultrasonography revealed hepatomegaly and acalculous cho-
lecystitis with a thickened edematous gallbladder measuring
11 mm (see Fig. 1). Intravenous ampicillin, gentamicin, and
metronidazole were commenced, and the patient underwent
urgent laparoscopic cholecystectomy given concern for pos-
sible gangrenous gallbladder. Histopathology showed acute
cholecystitis with a diffuse infiltrate of lymphocytes, plasma
cells, and occasional neutrophils. The patient defervesced
postoperatively and was discharged 5 days after operation. Q
fever was diagnosed by positive PCR from gallbladder tissue.
Initial screening PCR assay using a Com 1–gene target was
positive, and this was confirmed with a second PCR assay
targeting the IS1111, a sequence in the Coxiella burnetii ge-
nome. Serological testing showed a rise in complement fixa-
tion titer from <8 to >256 after 11 days. PCR on blood from
admission and day 6 were subsequently tested, and C. burnetii
genome was detected on both assays.
Q fever is a zoonosis caused by C. burnetii. Q fever has a
worldwide distribution, with the exception of New Zealand.
The majority of human infections are acquired by inhalation of
small particle droplets from urine, feces, milk, or bodily fluid
from cattle, sheep, goats, or native animals. C. burnetii causes
an initial bacteremia with widespread tissue seeding and
consequently has a diverse range of clinical manifestations.
1Department of Immunology, Allergy, and Infectious Disease, St. George Hospital, Sydney, Australia.
2Australian Rickettsial Reference Laboratory, Geelong, Australia.
3Department of Public Health Unit, South Eastern Sydney and Illawarra Health, Sydney, Australia.
VECTOR-BORNE AND ZOONOTIC DISEASES
Volume 10, Number 4, 2010
ª Mary Ann Liebert, Inc.
DOI: 10.1089=vbz.2008.0209
421
Acalculous cholecystitis has been described in association
with Q fever (Rolain et al. 2003). Acalculous cholecystitis is a
condition most commonly seen in patients critically unwell
from a variety of conditions, including sepsis, trauma, or
burns. Acalculous cholecystitis has been described as a direct
complication of several microorganisms, including Salmonella
spp., Mycobacterium spp., Plasmodium spp., Candida spp., cy-
tomegalovirus, cryptosporidium, and microspora (Barie and
Eachempati 2003). Such cases have been successfully man-
aged with medical therapy directed at the specific organism.
Fifteen cases of Q fever–associated cholecystitis have been
described (Kelly et al. 1986, Isaacs and Donald 1998, Modol
et al. 1999, Rolain et al. 2003, Gonzalez-Delgado et al. 2005,
Reina-Serrano et al. 2005, Hartzell et al. 2007). Two cases were
diagnosed by liver biopsy with histopathology showing
classic doughnut hole and fibrin ring surrounding a granu-
loma. The remainder were diagnosed by serology weeks after
the initial illness. Immunohistochemistry was nondiagnostic
for Q fever in all six patients who underwent cholecystectomy.
This is the first case described of Q fever cholecystitis di-
agnosed from gallbladder tissue. The presence of C. burnetii
genome in this patient, together with the clinical presentation,
acute cholecystitis, and seroconversion, suggests that C. bur-
netii may be directly involved in the pathogenesis of chole-
cystitis.
Molecular techniques are evolving as useful tools to make
an early diagnosis of Q fever. New techniques utilizing
htpAB-associated repetitive element of C. burnetii genome
(IS1111) have been shown in an outbreak setting to have a
sensitivity of 59% on serum (Turra et al. 2006). Sensitivity is
highest in early infection, before immunoglobulin M rise.
Molecular techniques may allow a more rapid diagnosis of
Q fever cholecystitis, facilitating earlier implementation of
specific treatment and reducing the likelihood of operation.
Despite early medical management with doxycycline, patients
may still develop complications such as secondary bacterial
infection, abscess formation, and perforation necessitating
surgical intervention.
The annual incidence of Q fever cases notified in Australia
has decreased from 5.0 per 100,000 in 1993, to 2.2 cases per
100,000 persons in 2004 (Brotherton et al. 2007). This re-
duction has been attributed to implementation between 2001
and 2004 of the National Q Fever Management Program,
which targeted abattoir workers, those contracted to abat-
toirs, sheep shearers, and sheep, dairy, and cattle farmers
and their employees. The patient described in this case
would not have been identified as part of the program but
was in a high-risk occupational group for which immuni-
zation is recommended. Australian guidelines recommend
Q fever vaccine for abattoir workers, farmers, stockyard
workers, shearers, animal transporters, others exposed to
cattle, sheep, goats, and kangaroos or their products, and
veterinarians and laboratory staff handling C. burnetii spec-
imens. In this instance, a recommendation was made to the
employer by Work Cover New South Wales that employees
working in the meat-packing industry with negative Q fever
serology be vaccinated and personal protective equipment
(goggles, mask, gown, and gloves) be worn when operating
the band saw.
Ongoing vigilance is required to prevent Q fever in high-
risk groups. Of concern is the high proportion of Q fever cases
occurring in groups with no recognized risk factors. Of the 15
described cases of Q fever–associated cholecystitis, only 4 had
documented animal exposure. The proportion of Australian Q
fever cases in people with no direct animal contact may in-
crease during drought, as the subsequent dusty conditions
enhance dissemination of this organism.
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